Skip to main content
Erschienen in: Supportive Care in Cancer 1/2023

01.01.2023 | Research

Dyadic coping in young and middle-aged women with gynecological cancer: a latent class analysis

verfasst von: Meimei Shang, Tingting Cai, Yingtao Meng, Qian Wang, Yongchun Cui, Fang Zhang

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cancer is a shared stress that can cause psychosocial and emotional burdens for both patients and their partners. This study aimed to identify patterns of dyadic coping (DC) among young and middle-aged women with gynecological cancer and to assess between-group differences.

Methods

Between June 2021 and November 2021, patients with gynecological cancer who received therapy in a tertiary-grade hospital in Shandong, China, completed questionnaires including a demographic questionnaire, the Dyadic Coping Inventory, the PROMIS-Anxiety Short Form, the PROMIS-Depression Short Form, and the revised Conflict Tactics Scale and were classified into subtypes by latent class analysis.

Results

The sample consisted of 339 patients. Approximately one-third of the patients, especially cervical cancer patients, were exposed to varying degrees of DC issues. Three patterns were identified: class 1, middle-DC group (33.6%); class 2, low-DC group (32.2%); and class 3, high-DC group (34.2%). Postmenopausal patients were more likely to be included in class 1, while patients with cervical cancer were more likely to be included in class 2 (p < 0.05). Additionally, patients in class 2 were more likely to report insufficient emotional support (p < 0.05). A positive correlation was found for social relationship domains, and a negative correlation was found for anxiety and depression (p < 0.05).

Conclusion

The findings indicated a high prevalence of DC in young and middle-aged women with gynecological cancer. Overall, participants scored in the low-to-middle range in terms of DC levels, and patients with cervical cancer and those with insufficient emotional support were more likely to report DC issues and require additional attention.
Literatur
4.
Zurück zum Zitat Weißflog G, Hönig K, Gündel H, Lang D, Niederwieser D, Döhner H, Ernst J (2016) Associations between dyadic coping and supportive care needs: findings from a study with hematologic cancer patients and their partners. Support Care Cancer 25:1444–1454. https://doi.org/10.1007/s00520-016-3541-3 Weißflog G, Hönig K, Gündel H, Lang D, Niederwieser D, Döhner H, Ernst J (2016) Associations between dyadic coping and supportive care needs: findings from a study with hematologic cancer patients and their partners. Support Care Cancer 25:1444–1454. https://​doi.​org/​10.​1007/​s00520-016-3541-3
18.
Zurück zum Zitat Huang Q, Wu F, Cai T (2022) Psychometric properties of Chinese version PROMIS anxiety and depression short form among patients with breast cancer in China. J Nurs Training 37(3):193–198 Huang Q, Wu F, Cai T (2022) Psychometric properties of Chinese version PROMIS anxiety and depression short form among patients with breast cancer in China. J Nurs Training 37(3):193–198
32.
Zurück zum Zitat Liu B, Wu X, Shi L, Li H, Wu D, Lai X, Li Y, Yang Y, Li D (2021) Correlations of social isolation and anxiety and depression symptoms among patients with breast cancer of Heilongjiang province in China: the mediating role of social support. Nurs Open 8(4):1981–1989. https://doi.org/10.1002/nop2.876CrossRef Liu B, Wu X, Shi L, Li H, Wu D, Lai X, Li Y, Yang Y, Li D (2021) Correlations of social isolation and anxiety and depression symptoms among patients with breast cancer of Heilongjiang province in China: the mediating role of social support. Nurs Open 8(4):1981–1989. https://​doi.​org/​10.​1002/​nop2.​876CrossRef
36.
38.
Zurück zum Zitat Okati-Aliabad H, Ansari-Moghadam A, Mohammadi M, Kargar S, Shahraki-Sanavi F (2022) The prevalence of anxiety and depression and its association with coping strategies, supportive care needs, and social support among women with breast cancer. Support Care Cancer 30:703–710. https://doi.org/10.1007/s00520-021-06477-2CrossRef Okati-Aliabad H, Ansari-Moghadam A, Mohammadi M, Kargar S, Shahraki-Sanavi F (2022) The prevalence of anxiety and depression and its association with coping strategies, supportive care needs, and social support among women with breast cancer. Support Care Cancer 30:703–710. https://​doi.​org/​10.​1007/​s00520-021-06477-2CrossRef
39.
Zurück zum Zitat Bodschwinna D, Ernst J, Mehnert-Theuerkauf A, Gündel H, Weissflog G, Hönig K (2021) Dyadic coping and social support: various types of support in hematooncological patients and their spouses-associations with psychological distress. Psychooncology 30:1041–1050. https://doi.org/10.1002/pon.5631CrossRef Bodschwinna D, Ernst J, Mehnert-Theuerkauf A, Gündel H, Weissflog G, Hönig K (2021) Dyadic coping and social support: various types of support in hematooncological patients and their spouses-associations with psychological distress. Psychooncology 30:1041–1050. https://​doi.​org/​10.​1002/​pon.​5631CrossRef
Metadaten
Titel
Dyadic coping in young and middle-aged women with gynecological cancer: a latent class analysis
verfasst von
Meimei Shang
Tingting Cai
Yingtao Meng
Qian Wang
Yongchun Cui
Fang Zhang
Publikationsdatum
01.01.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-022-07515-3

Weitere Artikel der Ausgabe 1/2023

Supportive Care in Cancer 1/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.